- The two-day event will feature presentations by eminent psychedelics companies and industry leaders
- Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST
TORONTO, ON / January 25, 2021 / Novamind Inc. (CSE:NM) (“Novamind” or the “Company”), a mental health company specialized in psychedelic medicine, today announced the Company’s participation at the Psychedelics Investor Conference, hosted by KCSA Strategic Communications on Tuesday, January 26th and Wednesday, January 27th from 9:00 AM – 12:30 PM EST.
The two-day event will feature presentations by eminent psychedelics companies and industry leaders. Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST.
“We look forward to connecting with industry leaders and investors to discuss Novamind’s operating model for clinical care and clinical research in psychedelic medicine,” said Conforti.
Read more: https://agoracom.com/ir/Novamind/forums/discussion/topics/753850-novamind-to-present-at-inaugural-kcsa-psychedelics-investor-conference/messages/2300029#message
Tags: COMPASS PATHWAYS, CSE, Field Trip Health Ltd., MIND MEDICINE (MINDMED) INC, NUMINUS WELLNESS INC, Psyched Wellness Ltd., Psychedelic, psychedelic medicine, Revive Therapeutics, small cap stocks, stocks, tsx, tsx-v, wellness clinics